{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:12:05Z","timestamp":1791900725833,"version":"4.3.4"},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"43","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,10,25]]},"DOI":"10.18632\/oncotarget.11824","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T11:25:51Z","timestamp":1472815551000},"page":"70185-70193","source":"Crossref","is-referenced-by-count":40,"title":["A meta-analysis of weekly cisplatin versus three weekly cisplatin chemotherapy plus concurrent radiotherapy (CRT) for advanced head and neck cancer (HNC)"],"prefix":"10.18632","volume":"7","author":[{"given":"Jian","family":"Guan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanjie","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Forastiere","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"2","unstructured":"NCCN Clinical Practice Guidelines in Oncology:Head and Neck Cancers. Version 1. 2015."},{"key":"3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Bourhis","year":"2009","journal-title":"Radiotherapy and Oncology"},{"key":"4","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/1097-0142(19901101)66:9<1861::AID-CNCR2820660902>3.0.CO;2-I","article-title":"Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17","volume":"66","author":"V\u00e9lez-Garc\u00eda","year":"1990","journal-title":"Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/annonc\/mdq219","article-title":"Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma oforopharynx and nasopharynx using weekly cisplatin:a phase II randomized trial","volume":"21","author":"Bhasker","year":"2010","journal-title":"Annals of Oncology"},{"key":"6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/1748-717X-7-215","article-title":"The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity","volume":"7","author":"Chang","year":"2012","journal-title":"Radiation Oncology"},{"key":"7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.oraloncology.2014.01.001","article-title":"Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV\/p16-positiveand negative head and neck squamous cell carcinoma","volume":"50","author":"Molina","year":"2014","journal-title":"Oral oncology"},{"key":"8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0973-1482.27584","article-title":"Comparison of acute toxicities of two chemotherapy schedules for head and neck cancers","volume":"2","author":"Kuriakose","year":"2006","journal-title":"Journal of cancer research and therapeutics"},{"key":"9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.oraloncology.2011.10.005","article-title":"Weekly and 3-weekly cisplatin concurrent with intensity-modulatedradiotherapy in locally advanced head and neck squamous cell cancer","volume":"48","author":"Richetti","year":"2012","journal-title":"Oral Oncology"},{"key":"10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00280-008-0911-7","article-title":"The comparison of weekly and three-weekly cisplatin chemotherapy concurrent with radiotherapy in patients with previously untreated inoperable non-metastatic squamous cell carcinoma of the head and neck","volume":"64","author":"Uzunoglu","year":"2009","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"11","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1080\/02841860701846160","article-title":"Dose intensity comparison between weekly and 3-weekly Cisplatindelivered concurrently with radical radiotherapy for head and neckcancer: A retrospective comparison from New Cross Hospital, Wolverhampton, UK","volume":"47","author":"Brammer","year":"2008","journal-title":"Acta Oncologica"},{"key":"12","first-page":"836","article-title":"Different Administration Regimens of Cisplatin Combined withConcurrent Radiotherapy for 65 Cases with Locally AdvancedNasopharyngeal Carcinoma","volume":"15","author":"Li","year":"2009","journal-title":"Journal of Oncology"},{"key":"13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/COC.0b013e31826b9b1a","article-title":"Dose Delivery Analysis of Weekly Versus 3-Weekly CisplatinConcurrent With Radiation Therapy for Locally AdvancedNasopharyngeal Carcinoma (NPC)","volume":"37","author":"Ho","year":"2014","journal-title":"American Journal of Clinical Oncology"},{"key":"14","first-page":"1185","article-title":"Weekly Cisplatin versus Standard Three-weekly Cisplatin in Concurrent Chemoradiotherapy of Head and Neck Cancer: the Baskent University Experience","volume":"12","author":"Ozyilkan","year":"2011","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"key":"15","doi-asserted-by":"crossref","first-page":"e110765","DOI":"10.1371\/journal.pone.0110765","article-title":"Comparison of long-term survival and toxicity of cisplatin delivered weekly versus every three weeks concurrently with intensity-modulated radiotherapy in nasopharyngeal carcinoma","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12254-014-0143-y","article-title":"Follow-up in patients treated for head and neck cancer","volume":"7","author":"Krajewski","year":"2014","journal-title":"Magazine of European medical oncology"},{"key":"17","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1200\/JCO.2005.16.790","article-title":"Randomized Trial of Radiotherapy Versus Concurrent Chemoradiotherapy Followed by Adjuvant Chemotherapy in Patients With American Joint Committee on Cancer\/International Union Against Cancer Stage III and IV Nasopharyngeal Cancer of the Endemic Variety","volume":"23","author":"Loong","year":"2005","journal-title":"Journal of clinical oncology"},{"key":"18","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099","volume":"16","author":"Ensley","year":"1998","journal-title":"Journal of clinical oncology"},{"key":"19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"Journal of the National Cancer Institute"},{"key":"20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0360-3016(99)00138-8","article-title":"Avoidance of treatment interruption: an unrecognized benefit of accelerated RT in Oropharyngeal carcinoma?","volume":"45","author":"Kurtz","year":"1999","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"21","doi-asserted-by":"publisher","first-page":"38381","DOI":"10.18632\/oncotarget.5420","article-title":"Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost","volume":"6","author":"Hu","year":"2015","journal-title":"Oncotarget"},{"key":"22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000226941","article-title":"Simultaneous cisplatin and RT in inoperable or locally advanced squamous cell carcinoma of the head and neck","volume":"48","author":"Dal Fior","year":"1991","journal-title":"Oncology"},{"key":"23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2010.06.038","article-title":"Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382)","volume":"81","author":"Forastiere","year":"2011","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"24","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Kirkpatrick","year":"2004","journal-title":"The New England journal of medicine"},{"key":"25","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0360-3016(90)90226-A","article-title":"Cisplatin and radiation: interaction probabilities and therapeutic possibilities","volume":"19","author":"Begg","year":"1990","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s004050050190","article-title":"Radiosensitization of advanced squamous cell carcinoma of the head and neck with cisplatinduring concomitant radiation therapy","volume":"256","author":"Wilson","year":"1999","journal-title":"European archives of oto-rhino-laryngology"},{"key":"27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0360-3016(91)90689-2","article-title":"Concomitant CT-radiation therapy followed by hyperfractionated radiation therapy for advanced unresectable head and neck cancer","volume":"21","author":"Bosl","year":"1991","journal-title":"International journal of radiation oncology, biology, physics"},{"key":"28","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Chao","year":"2004","journal-title":"The New England journal of medicine"},{"key":"29","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1088\/0031-9155\/51\/15\/002","article-title":"Scheduling cisplatin and radiotherapy in the treatment of squamous cell carcinomas of the head and neck: a modelling approach","volume":"51","author":"Olver","year":"2006","journal-title":"Physics in medicine and biology"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24281","article-title":"Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer","author":"van Herpen","year":"2015","journal-title":"Head & neck"},{"key":"31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/gyno.2000.5810","article-title":"Analysis of the cost effectiveness of concurrent cisplatin-based chemoradiation in cervical cancer: implications from five randomized trials","volume":"78","author":"Lappas","year":"2000","journal-title":"Gynecologic oncology"},{"key":"32","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/hed.21601","article-title":"Cost-effectiveness analysis of cisplatin-based chemoradiation to treat patients with unresectable, nonmetastatic head and neck cancer in Brazil","volume":"33","author":"Federico","year":"2011","journal-title":"Head and neck"},{"key":"33","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/jjco\/hyu067","article-title":"Head and Neck Cancer Study Group of the Japan Clinical Oncology Group. Randomized phase II\/III trial of post-operative chemoradiotherapy comparing 3-weekly cisplatin with weekly cisplatin in high-risk patients with squamous cell carcinoma of head and neck: Japan Clinical Oncology Group Study (JCOG1008)","volume":"44","author":"Fujii","year":"2014","journal-title":"Japanese journal of clinical oncology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T13:43:35Z","timestamp":1589291015000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":33,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2016,10,25]]}},"alternative-id":["11824","27602493"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11824","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}